Enlarge / The Comirnaty (Pfizer/BioNTech) and Moderna COVID-19 vaccines. reader comments 511 with Share this story Two Republican lawmakers in Idaho have introduced a bill that would make it a misdemeanor for anyone in the state to administer mRNA-based vaccines—namely the lifesaving and remarkably safe COVID-19 vaccines made by Pfizer-BioNTech and Moderna. If passed as ..
Tag : BioNTech
reader comments 31 with 29 posters participating Share this story The new bivalent COVID-19 booster spurred neutralizing antibody levels that were fourfold higher against the omicron subvariants BA.4/BA.5 in older adults than those seen after the original booster, Pfizer reported Friday. The new data may help calm concerns about whether the updated booster is an ..
Enlarge / Moderna states that it doesn’t want to halt production or distribution of Pfizer/BioNTech’s vaccine, but it does want to be paid a license for its claimed patents. Getty Images reader comments 41 with 34 posters participating Share this story Now that the vaccine race is over and shots are broadly available, Moderna has ..
reader comments 247 with 84 posters participating Share this story The Food and Drug Administration is considering holding off on reviewing Moderna’s COVID-19 vaccine for children under age 5 until it has data from Pfizer and BioNTech on their vaccine for young children. The plan would push back the earliest possible authorization for a vaccine ..
Enlarge / Vials of undiluted Pfizer COVID-19 vaccine. reader comments 53 with 33 posters participating Share this story Vaccine makers are pushing back when omicron-specific COVID-19 vaccines could be ready for use. The shots were initially expected in March. Delays in the vaccines’ development come as cases of omicron have been dropping rapidly, and several ..
Enlarge / A child getting a vaccination on February 19, 2021, in Bonn, Germany. reader comments 75 with 48 posters participating Share this story Covid-19 Coverage View more stories The Food and Drug Administration, Pfizer, and BioNTech announced on Friday that they are abandoning plans to pursue the authorization of a two-dose regimen of COVID-19 ..
Enlarge / A tray of prepared syringes for booster vaccinations with Moderna’s vaccine. reader comments 153 with 90 posters participating Share this story Covid-19 Coverage View more stories The Food and Drug Administration has authorized booster doses of both the Pfizer-BioNTech and Moderna COVID-19 vaccines for all people ages 18 and up, the companies announced ..
Enlarge / The Food and Drug Administration headquarters in White Oak, Maryland. reader comments 72 with 52 posters participating Share this story Covid-19 Coverage View more stories As expected, a committee of independent advisors for the Food and Drug Administration voted unanimously (19-to-0) Thursday afternoon in favor of authorizing a booster dose of Moderna’s COVID-19 ..
Enlarge / Boxes of Johnson & Johnson’s Janssen COVID-19 vaccine at a vaccination site in Florida. reader comments 79 with 42 posters participating Share this story Covid-19 Coverage View more stories Johnson & Johnson plans to seek authorization for a booster dose for its one-shot COVID-19 vaccine early this week, according to a report by ..
Enlarge / Empty Pfizer-BioNTech COVID-19 vaccine vials reader comments 229 with 131 posters participating Share this story Covid-19 Coverage View more stories The Food and Drug Administration has granted full approval of the Pfizer/BioNTech COVID-19 vaccine, which will now be marketed as Comirnaty (koe-mir’-na-tee), the agency announced Monday. The vaccine’s full approval—or Biologics License Application ..